ClassID:

108876

C12N9/0075 - CPC Classification

Classification description:

Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13 Nitric-oxide synthase (1.14.13.39)

Recent Application in this class:
#1
20250325009
2025-10-23

COLOR FORMER BASED ON FUSION ENZYME PRODUCING NITRIC OXIDE AND USE THEREOF

#2
20250263760
2025-08-21

MODIFIED BACTERIA FOR PRODUCTION OF NITROAROMATICS

#3
20240229090
2024-07-11

Methods for producing modified bacteria for production of nitroaromatics

#4
20230287466
2023-09-14

Modified bacteria for production of nitroaromatics

#5
20230220021
2023-07-13

CYCLIC PEPTIDE INHIBITORS OF PSD-95 AND USES THEREOF

#6
20210363501
2021-11-25

In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject

#7
20210108237
2021-04-15

Modified bacteria for production of nitroaromatics

#8
20210024895
2021-01-28

RNA preparations comprising purified modified RNA for reprogramming cells

#9
20200216824
2020-07-09

REGULATING PROTEIN SPONTANEOUS RUPTURES

#10
20190314421
2019-10-17

NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE

#11
20190112582
2019-04-18

In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject

#12
20190017082
2019-01-17

Increased triacylglycerol production in microalgae

#13
20190000090
2019-01-03

BIOFILMS, COMPONENTS AND METHODS OF USE TO REDUCE BIOFOULING AND CONTAMINATION

#14
20180265848
2018-09-20

RNA preparations comprising purified modified RNA for reprogramming cells

#15
20170252376
2017-09-07

NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE

#16
20170112136
2017-04-27

Biofilms, components and methods of use to reduce biofouling and contamination

#17
20170087221
2017-03-30

NITRIC OXIDE-MODULATING BONE-TARGETING COMPLEXES

#18
20170002043
2017-01-05

Peptides and methods and uses thereof for preventing retinal disorders

#19
20160369243
2016-12-22

RNA preparations comprising purified modified RNA for reprogramming cells

#20
20160368877
2016-12-22

2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition

#21
20160220647
2016-08-04

PROTEINS FOR TARGETING NEURONAL NITRIC OXIDE SYNTHASE TO MUSCLE SARCOLEMMA AND RELATED METHODS OF USE

#22
20150018665
2015-01-15

MOLECULAR AND CELLULAR IMAGING USING ENGINEERED HEMODYNAMIC RESPONSES

#23
20140371161
2014-12-18

Peptides and methods and uses thereof for preventing retinal disorders

#24
20130267470
2013-10-10

Treatment of penetrative injury to the brain

#25
20130224827
2013-08-29

ENDOTHELIAL NITRIC OXIDE SYNTHASE

#26
20130040359
2013-02-14

Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition

#27
20120308570
2012-12-06

METHODS FOR TREATING DISEASES

#28
20120115785
2012-05-10

Endothelial nitric oxide synthase antagonists and uses thereof for inhibiting oxygen toxicity

#29
20110173711
2011-07-14

eNos Mutations Useful for Gene Therapy and Therapeutic Screening

#30
20110143436
2011-06-16

Compositions and methods for reprogramming eukaryotic cells

#31
20100190230
2010-07-29

Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability

#32
20100029920
2010-02-04

METHOD FOR ASSESSING THE EFFECT OF A DRUG ON LONG TERM MEMORY FORMATION

#33
20090246183
2009-10-01

eNOS mutations useful for gene therapy and therapeutic screening

#34
20080263683
2008-10-23

Megsin/Rage/Inos-Overexpressing Renal Disease Model Animals and Methods for Evaluating Compounds Using the Model Animals

#35
20070071725
2007-03-29

Nitric oxide synthase gene transfer

#36
20060134089
2006-06-22

Nitric oxide synthase gene transfer to the atrium for vagal tone increase

#37
20060009407
2006-01-12

Enhancement of vascular function by modulation of endogenous nitric oxide production or activity

#38
20050281744
2005-12-22

Method for assessing the effect of a drug on long term memory formation

#39
20050042645
2005-02-24

Bacterial nitric oxide synthases and uses thereof

#40
20050019854
2005-01-27

Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase